LDH inhibitors as treatment for fibrosis and fibrotic-related disorders
AssigneeUniversity of Rochester
InventorsRobert M. Kottmann, Patricia J. Sime, Richard P. Phipps
Life of this patent
Estimating the term…
Abstract
One aspect of the disclosure relates to methods of treating a fibrotic condition in an individual. The methods include administering to an individual having a fibrotic condition an effective amount of a lactic dehydrogenase (LDH) inhibitor, wherein the fibrotic condition involves an internal organ or tissue, or ocular tissue, and said administering is effective to treat the fibrotic condition. Methods of administration and pharmaceutical compositions and systems for practicing such methods are also disclosed.
Claims15
A method of treating a fibrotic condition in an individual, said method comprising:
- administering to an individual having a fibrotic condition an effect amount of a lactic dehydrogenase (LDH) inhibitor, wherein the fibrotic condition involves an internal organ or tissue, or ocular tissue, and said administering is effective to treat the fibrotic condition, and wherein the fibrotic condition is not a cancerous proliferative disorder, idiopathic arthrofibrosis, or dermatological scarring.
Dependencies are inferred from the claim text.